| Literature DB >> 27587396 |
Dezerae Cox1,2, Emily Selig3, Michael D W Griffin3, John A Carver4, Heath Ecroyd5,2.
Abstract
The aggregation of α-synuclein (α-syn) into amyloid fibrils is associated with neurodegenerative diseases, collectively referred to as the α-synucleinopathies. In vivo, molecular chaperones, such as the small heat-shock proteins (sHsps), normally act to prevent protein aggregation; however, it remains to be determined how aggregation-prone α-syn evades sHsp chaperone action leading to its disease-associated deposition. This work examines the molecular mechanism by which two canonical sHsps, αB-crystallin (αB-c) and Hsp27, interact with aggregation-prone α-syn to prevent its aggregation in vitro Both sHsps are very effective inhibitors of α-syn aggregation, but no stable complex between the sHsps and α-syn was detected, indicating that the sHsps inhibit α-syn aggregation via transient interactions. Moreover, the ability of these sHsps to prevent α-syn aggregation was dependent on the kinetics of aggregation; the faster the rate of aggregation (shorter the lag phase), the less effective the sHsps were at inhibiting fibril formation of α-syn. Thus, these findings indicate that the rate at which α-syn aggregates in cells may be a significant factor in how it evades sHsp chaperone action in the α-synucleinopathies.Entities:
Keywords: Parkinson disease; amyloid; analytical ultracentrifugation; fibril; molecular chaperone; protein aggregation; small heat shock protein (sHsp); synuclein; α-synuclein (a-synuclein)
Mesh:
Substances:
Year: 2016 PMID: 27587396 PMCID: PMC5077198 DOI: 10.1074/jbc.M116.739250
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157